EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors

Hina Aftab, Saeed Ullah, Ajmal Khan, Mariya Al-Rashida, Talha Islam, Abdulrahman Alshammari, Norah A Albekairi, Parham Taslimi iD, Ahmed Al-Harrasi, Zahid Shafiq iD, Saeed Alghamdi

RSC Advances · 2024 · 14 (43) · 31409-31421

DOI: 10.1039/d4ra05071a ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2024. Verfasst von Hina Aftab und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan zahidshafiq@bzu.edu.pk. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: King Saud University, Alexander von Humboldt-Stiftung.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dihydrofolate reductase (DHFR) is a crucial enzyme involved in folate metabolism and serves as a prime target for anticancer and antimicrobial therapies.

Autor:innen und Institutionen

  • Institute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan zahidshafiq@bzu.edu.pk.
  • Natural and Medical Sciences Research Centre, University of Nizwa P.O. Box 33, PC 616, Birkat Al Mauz Nizwa Sultanate of Oman aharrasi@unizwa.edu.om.
  • Department of Chemical and Biological Engineering, College of Engineering, Korea University 145 Anam-ro, Seongbuk-gu Seoul 02841 Republic of Korea.
  • Department of Chemistry, Forman Christian College (A Chartered University) Lahore Pakistan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University Post bezBox 2455 Riyadh 11451 Saudi Arabia.
  • Department of Biotechnology, Faculty of Science, Bartin University 74100 Bartin Turkey.

ORCID-Profile: Parham Taslimi, Zahid Shafiq

Förderung

  • King Saud University
  • Alexander von Humboldt-Stiftung

Zitieren

APA

Aftab, H., Ullah, S., Khan, A., Al-Rashida, M., Islam, T., Alshammari, A., Albekairi, N. A., Taslimi, P., Al-Harrasi, A., Shafiq, Z., & Alghamdi, S. (2024). Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors. RSC Advances, 14(43), 31409-31421. https://doi.org/10.1039/d4ra05071a

Vancouver

Aftab H, Ullah S, Khan A, Al-Rashida M, Islam T, Alshammari A, et al. Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors. RSC Advances. 2024;14(43):31409-31421. doi:10.1039/d4ra05071a

BibTeX
@article{Aftab2024,
  author = {Aftab, Hina and Ullah, Saeed and Khan, Ajmal and Al-Rashida, Mariya and Islam, Talha and Alshammari, Abdulrahman and Albekairi, Norah A and Taslimi, Parham and Al-Harrasi, Ahmed and Shafiq, Zahid and Alghamdi, Saeed},
  title = {Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors},
  journal = {RSC Advances},
  year = {2024},
  volume = {14},
  number = {43},
  pages = {31409--31421},
  doi = {10.1039/d4ra05071a}
}
Kostenlos starten →